# Caplacizumab (Genetical Recombination) for Injection 10mg (カブリビ注射用１０ｍｇ)

> Prescription product approved in Japan and listed on the NHI drug price list (YJ code 3399415D1027). Nifuji Pharma sources it for licensed healthcare providers, institutions, and distributors; availability, documentation, and export eligibility are confirmed on inquiry.

- **YJ code:** 3399415D1027
- **Product name (Japanese):** カブリビ注射用１０ｍｇ
- **English title:** Caplacizumab (Genetical Recombination) for Injection 10mg
- **Active ingredient:** カプラシズマブ（遺伝子組換え）
- **Active ingredient (INN):** Caplacizumab (Genetical Recombination)
- **Strength / unit:** １０ｍｇ１瓶（溶解液付）
- **Route:** Injection (注射薬)
- **Therapeutic category:** 33 Blood and body fluid agents (血液・体液用薬) › 339 Other blood and body fluid agents (その他の血液・体液用薬)
- **Manufacturer:** Sanofi (サノフィ)
- **NHI price (reference only):** JPY 515532 per １０ｍｇ１瓶（溶解液付）
- **Regulatory status:** Approved in Japan; listed on the NHI drug price list
- **Web page:** https://www.nifujipharma.com/drugs/3399415D1027
- **JSON:** https://www.nifujipharma.com/api/drugs/3399415D1027

## How to request a quotation

Submit the contact form with the product name, quantity, and destination country: https://www.nifujipharma.com/?product=Caplacizumab%20(Genetical%20Recombination)%20for%20Injection%2010mg%20(%E3%82%AB%E3%83%96%E3%83%AA%E3%83%93%E6%B3%A8%E5%B0%84%E7%94%A8%EF%BC%91%EF%BC%90%EF%BD%8D%EF%BD%87)%20%2F%20YJ%203399415D1027#contact

Quotes are for qualified business customers only (licensed healthcare providers, medical institutions, distributors). Payment is by bank transfer in Japanese Yen. Product collection typically takes 2-4 weeks after order confirmation, followed by export procedures and shipping.